(16E)-14-Methyl-20-oxa-5,7,14,26-tetraazatetracyclo-[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8-(27),9,11,16,21,23-decaene (Compound)

Description: A compound in the knowledge graph

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View (16E)-14-Methyl-20-oxa-5,7,14,26-tetraazatetracyclo-[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8-(27),9,11,16,21,23-decaene's neighborhood in the knowledge graph.

Submit

Knowledge Graph Assertions

Source	Relation	Target	Evidence
(16E)-14-Methyl-20-oxa-5,7,14,26-tetraazatetracyclo-[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8-(27),9,11,16,21,23-decaene Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Receptor-type tyrosine-protein kinase FLT3 Protein (Entity type)	IC50
(16E)-14-Methyl-20-oxa-5,7,14,26-tetraazatetracyclo-[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8-(27),9,11,16,21,23-decaene Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Tyrosine-protein kinase JAK1 Protein (Entity type)	IC50
(16E)-14-Methyl-20-oxa-5,7,14,26-tetraazatetracyclo-[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8-(27),9,11,16,21,23-decaene Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Cyclin-dependent kinase 1 Protein (Entity type)	IC50
(16E)-14-Methyl-20-oxa-5,7,14,26-tetraazatetracyclo-[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8-(27),9,11,16,21,23-decaene Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Cytochrome P450 2D6 Protein (Entity type)	IC50
(16E)-14-Methyl-20-oxa-5,7,14,26-tetraazatetracyclo-[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8-(27),9,11,16,21,23-decaene Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Non-receptor tyrosine-protein kinase TYK2 Protein (Entity type)	IC50
(16E)-14-Methyl-20-oxa-5,7,14,26-tetraazatetracyclo-[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8-(27),9,11,16,21,23-decaene Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Cyclin-dependent kinase 3 Protein (Entity type)	IC50
(16E)-14-Methyl-20-oxa-5,7,14,26-tetraazatetracyclo-[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8-(27),9,11,16,21,23-decaene Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Cyclin-dependent kinase 9 Protein (Entity type)	IC50
(16E)-14-Methyl-20-oxa-5,7,14,26-tetraazatetracyclo-[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8-(27),9,11,16,21,23-decaene Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Cyclin-dependent kinase 2 Protein (Entity type)	IC50
(16E)-14-Methyl-20-oxa-5,7,14,26-tetraazatetracyclo-[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8-(27),9,11,16,21,23-decaene Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Macrophage colony-stimulating factor 1 receptor Protein (Entity type)	IC50
(16E)-14-Methyl-20-oxa-5,7,14,26-tetraazatetracyclo-[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8-(27),9,11,16,21,23-decaene Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	AarF domain-containing protein kinase 1 Protein (Entity type)	Kd